Antibacterial therapy of community-acquired pneumonia (review of literal and the authors’ data, clinical efficacy of guidelines)
Abstract
This comparative study involved 540 community-acquired pneumonia patients treated in a multi-profile hospital. A retrospective comparative analysis of antibacterial therapy efficacy before (250 patients) and after (290 patients) implication of a technological card considering modern clinical guidelines was made. The results demonstrated improvement in quality and efficiency of treatment of the pneumonia patients when using the modern guidelines.
About the Authors
G. I. Nazarenko
Медицинский центр Банка России;
ФУВ РГМУ
Russian Federation
Russian Federation
A. N. Antipin
Медицинский центр Банка России;
ФУВ РГМУ
Russian Federation
Russian Federation
Yu. K. Novikov
Медицинский центр Банка России;
ФУВ РГМУ
Russian Federation
Russian Federation
References
1. Bartlett J.G., Dowell S.F., Mandell L.A., et al. Practice guidelines for the management of comm unity-acquired pneumonia in adults. Clin. Infect. Dis. 2000; 31: 347-382.
2. Niedermann M.S., Mandell L.A., Anzueto A. et al. Guidelines for the management of community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am. J. Respir. Crit. Care Med. 2001; 163: 1730-1754.
3. Fine M.J., Smith M.A., Carson C.A. et al. Prognosis and outcome of patients with community-acquired pneumonia. A metaanalysis. J.A.M.A. 1996; 275: 134-141.
4. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. М.; 2003.
5. Battleman D.S., Callahan М., Thaler Н.Т. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia. Arch. Intern. Med. 2002; 162: 682-688.
6. Gleason P.P., Meehan T.P., Fine M.J. et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch. Intern. Med. 1999; 159: 2562-2572.
7. Dean N.C., Silver M.P., Bateman K.A. et al. Decreased mortality after implementation of a treatment guideline for communityacquired pneumonia. Am. J. Med. 2001; 110: 451-457.
8. Grant W. W., Gregory S.J., Richard G.W. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 1999; 116: 1278-1281.
9. Santiago E., Matthias S., Norbert G. et al. Applying sputum as a diagnostic tool in pneumonia. Chest 2002; 121: 1486-1492.
10. Ноников B.E. Внебольничные пневмонии: эмпирическая антибактериальная терапия. Рос. мед. журн. 2003; 11 (22): 1268-1272.
11. BTS. Guidelines for the management of com m unity-acquired pneumonia in adults. Thorax 2001; 56 (suppl. 4): 1-64.
12. Mandell L.A., Marrie T.J., Grossman R.F. et al. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and Canadian Thoracic Society. Clin. Infect. Dis. 2000; 31: 383.
13. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur. Respir. J. 1998; 11: 986 -991 .
14. David C.R. Overview of recent guidelines for the management of community-acquired pneumonia JC O M 2002; 9: 381 -389 .
15. Синопальников А.Я. Современный анализ рекомендаций по ведению больных внебольничной пневмонией: критический анализ. Клин, микробиол. и антимикроб, химиотер. 2003; 5 (3): 24-28.
16. Назаренко Г.И., Полубенцева Е.И. Управление качеством медицинской помощи. М.: Медицина; 2000.
17. David С. R. Quality indicators for the management of pneumonia in vulnerable elders. Ann. intern. Med, 2001; 135 (8 ): 736-743.
18. 7Д G.S., Meehan T.P., Fine M.J. et al. Which strategies facilitate improvement in quality of care for elderly hospitalized pneumonia patients? J. Commis. J. Quality Safety 2004; 30 (1): 25-35.
19. Meehan T.P., Fine M.J., Krumholz H.M. et al. Quality of care, process, and outcomes in elderly patients with pneumonia. J.A.M.A. 1997; 278: 2080-2084.
20. Pearson S.D., Goulart-Fisher D., Lee Т.Н. Critical pathway as a strategy for improving care: problems and potential. Ann. Intern. Med. 1995; 123: 941-948.
21. Marrie T.J., Lau C.Y., Wheller S.L. et al. A controlled trial of critical pathway for treatment of community-acquired pneumonia. J.A.M.A. 2000; 283 (6 ): 749 -754 .
22. Read R.C. Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia. J. Infect. 1999; 39 (3): 171-178.
23. Cuastro-Guardiola F., IPiejo-Rodrigues A.L., Soler-Sim on A. et al. Efficacy and safety of oral and early-switch therapy of community-acquired pneumonia: a randomised controlled trial. Am. J. Med. 2001; 111: 367-374.
24. Ramirez J.A., Vargas S., Ritter G.W. et al. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 2 0 0 consecutive patients with community-acquired pneumonia. Arch. Intern. Med. 1999; 159: 2449-2454.
25. Смоленое И.В. Роль неантибактериальных лекарственных средств в лечении пневмонии. Клин, микробиол. и антимикроб. химиотер. 2003; 5 (3): 18-23.
Review
For citations:
Nazarenko G.I., Antipin A.N., Novikov Yu.K. Antibacterial therapy of community-acquired pneumonia (review of literal and the authors’ data, clinical efficacy of guidelines). PULMONOLOGIYA. 2004;(4):60-66. (In Russ.)
Views:
183
Email this article 